Published online before print October 7, 2004, doi: 10.1161/01.STR.0000143728.45516.c6
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:2493.)
© 2004 American Heart Association, Inc.
Original Contributions |
Impact of Admission Hyperglycemia on Stroke Outcome After Thrombolysis
Risk Stratification in Relation to Time to Reperfusion
From the Neurovascular Unit, Department of Neurology, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Spain.
Correspondence to Dr José Alvarez-Sabín, Neurovascular Unit, Deparment of Neurology, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. E-mail josalvar{at}vhebron.net
Background and Purpose— We evaluated the impact of admission hyperglycemia (HG) on stroke outcome in relation to the timing of reperfusion in patients treated with tissue plasminogen activator (tPA).
Methods— We studied 138 consecutive stroke patients with a documented middle cerebral artery (MCA) occlusion treated with intravenous tPA <3 hours of stroke onset. Serum glucose was determined at baseline before tPA administration. HG was defined as a glucose level >140 mg/dL. National Institutes of Health Stroke Scale (NIHSS) scores were obtained at baseline and 24 hour. Transcranial Doppler monitoring of recanalization was conducted during the first 12 hour of stroke onset. mRS was used to assess outcome at 3 months.
Results— Median baseline NIHSS score was 17 points. At baseline, 42 (37.3%) patients were hyperglycemic and 96 (62.7%) normoglycemic. Reperfusion was achieved <3 hours of stroke onset in 32 (23%) patients, between 3 to 6 hours in 49 (36%), 6 to 12 hours in 15 (12%), and in 32 (23%) the MCA remained occluded at 12 hours. A logistic regression model revealed that baseline NIHSS score >16 points (odds ratio [OR], 3.32; 95% CI, 2.18 to 24.7; P=0.032) and admission glucose level >140 mg/dL (OR, 5.65; 95% CI, 1.97 to 16.18; P=0.002) independently predicted poor outcome (modified Rankin scale, 3 to 6) at 3 months. After adjusting by age, stroke severity, site of MCA occlusion, and degree of recanalization, the contribution of HG for poor outcome was higher as shorter the time to reperfusion. The highest odds for poor outcome related to HG corresponded to patients who recanalized <3 hour (OR, 3.1; 95% CI, 1.8 to 14.3; P=0.002), as compared with those who recanalized between 3 and 6 hours (OR, 2.1; 95% CI, 1.1 to 16; P=0.034) and between 6 to 12 hours (OR, 1.1; 95% CI, 0.7 to 21; P=0.43). Moreover, baseline glucose level was negatively correlated (r=–0.45; P=0.001) with the degree of improvement in the NIHSS score at 24 hours after early (<3 hours) but not after delayed (>3 hours) or no recanalization.
Conclusion— The impact of admission HG on stroke outcome varies depending on the time to tPA-induced reperfusion. The detrimental effect of acute HG is higher after early than after delayed or no reperfusion. Ultra-early glycemic control before reperfusion may improve the efficacy of thrombolytic therapy.
Key Words: hyperglycemia • outcome • stroke • thrombolysis
This article has been cited by other articles:
 |
|
 |
|
  D. S. Liebeskind Reversing Stroke in the 2010s: Lessons From Desmoteplase In Acute ischemic Stroke-2 (DIAS-2) Stroke, September 1, 2009; 40(9): 3156 - 3158. [Full Text] [PDF]
|
|
|
|
|
|
H. Hallevi, A. D. Barreto, D. S. Liebeskind, M. M. Morales, S. B. Martin-Schild, A. T. Abraham, J. Gadia, J. L. Saver, the UCLA Intra-Arterial Therapy Investigators, J. C. Grotta, et al. Identifying Patients at High Risk for Poor Outcome After Intra-Arterial Therapy for Acute Ischemic Stroke Stroke, May 1, 2009; 40(5): 1780 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. McCormick, K. W. Muir, C. S. Gray, and M. R. Walters Management of Hyperglycemia in Acute Stroke: How, When, and for Whom? Stroke, July 1, 2008; 39(7): 2177 - 2185. [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Pasternak, D. G. McGregor, D. R. Schroeder, W. L. Lanier, Q. Shi, B. J. Hindman, W. R. Clarke, J. C. Torner, J. B. Weeks, M. M. Todd, et al. Hyperglycemia in Patients Undergoing Cerebral Aneurysm Surgery: Its Association With Long-term Gross Neurologic and Neuropsychological Function Mayo Clin. Proc., April 1, 2008; 83(4): 406 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bruno, T. A. Kent, B. M. Coull, R. R. Shankar, C. Saha, K. J. Becker, B. M. Kissela, and L. S. Williams Treatment of Hyperglycemia In Ischemic Stroke (THIS): A Randomized Pilot Trial Stroke, February 1, 2008; 39(2): 384 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, May 22, 2007; 115(20): e478 - e534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Stroke, May 1, 2007; 38(5): 1655 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ganguly, J.-C. Murciano, R. Westrick, J. Leferovich, D. B. Cines, and V. R. Muzykantov The Glycocalyx Protects Erythrocyte-Bound Tissue-Type Plasminogen Activator from Enzymatic Inhibition J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 158 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rubiera, M. Ribo, R. Delgado-Mederos, E. Santamarina, P. Delgado, J. Montaner, J. Alvarez-Sabin, and C. A. Molina Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion: An Independent Predictor of Poor Outcome After Systemic Thrombolysis Stroke, September 1, 2006; 37(9): 2301 - 2305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Krinsley and R. L. Jones Cost Analysis of Intensive Glycemic Control in Critically Ill Adult Patients Chest, March 1, 2006; 129(3): 644 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ribo, C. Molina, J. Montaner, M. Rubiera, R. Delgado-Mederos, J. F. Arenillas, M. Quintana, and J. Alvarez-Sabin Acute Hyperglycemia State Is Associated With Lower tPA-Induced Recanalization Rates in Stroke Patients Stroke, August 1, 2005; 36(8): 1705 - 1709. [Abstract] [Full Text] [PDF]
|
|